The presence of an intronic deletion in p73 and high levels of ZEB1 alter the TAp73/ΔTAp73 ratio in colorectal carcinomas

Journal of Pathology

Volumn 210, Issue 4, 2006, Pages 390-397

  Dominguez G ^a   Pena C ^a   Silva, J ^a   Garcia J M ^a   Garcia V ^a   Rodriguez R ^b   Cantos, B ^a   Citores, M J ^a   Espana P ^a   Bonilla, F ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b HOSPITAL VIRGEN DE LA SALUD   (Spain)

Author keywords

TAp73; p300; p73 deletion; TAp73; ZEB1

Indexed keywords

ISOPROTEIN; PROTEIN CTBP; PROTEIN P300; PROTEIN P73; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ZEB1;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER STAGING; COLORECTAL CARCINOMA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; FEMALE; GENE DELETION; GENE OVEREXPRESSION; GENE REPRESSION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INTRON; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; ONCOLOGICAL PARAMETERS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; UPREGULATION;

AGED; ALCOHOL OXIDOREDUCTASES; COLORECTAL NEOPLASMS; DNA-BINDING PROTEINS; E1A-ASSOCIATED P300 PROTEIN; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; INTEINS; MALE; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTEIN ISOFORMS; RNA, MESSENGER; RNA, NEOPLASM; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; ZEBRAFISH PROTEINS;

EID: 33751541942     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2066     Document Type: Article

References (33)

1. Kaghad M, Bonnet H, Yang, Creancier L, Biscan JC, Valent A, et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 1997;90:809-819.
2. Irwin MS, Kaelin WG. p53 family update: p73 and p63 develop their own identities. Cell Growth Differ 2001;12:337-349.
3. Melino G, De Laurenzi V, Vousden KH. p73: friend or foe in tumorigenesis. Nature Rev Cancer 2002;2:605-615.
4. Moll UM, Erster S, Zaika A. p53, p63 and p73: solos, alliances and feuds among family members. Biochim Biophys Acta 2001;1552:47-59.
5. Yang A, Walker N, Bronson R, Kaghad M, Oosterwegel M, Bonnin J, et al. p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 2000;404:99-103.
6. Jost CA, Marin MC, Kaelin WG Jr. p73 is a simian [correction of human] p53-related protein that can induce apoptosis. Nature 1997;389:191-194.
7. Sherr CJ, Weber JD. The ARF/p53 pathway. Curr Opin Genet Dev 2000;10:94-99.
8. Zaika AI, Slade N, Erster SH, Sansome C, Joseph TW, Pearl M, et al. ΔNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors. J Exp Med 2002;196:765-780.
9. Pozniak CD, Radinovic S, Yang A, McKeon F, Kaplan DR, Miller FD. An anti-apoptotic role for the p53 family member, p73, during developmental neuron death. Science 2000;289:304-306.
10. Fillippovich I, Sorokina N, Gatei M, Haupt Y, Hobson K, Moallen E, et al. Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53. Oncogene 2001;20:514-522.
11. Stiewe T, Theseling CC, Putzer BM. Transactivation-deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding: implications for tumorigenesis. J Biol Chem 2002;277:14177-14185.
12. Agami R, Blandino G, Oren M, Shaul Y. Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis. Nature 1999;399:809-813.
13. Gong JG, Costanzo A, Yang HQ, Melino G, Kaelin WG Jr, Levrero M, et al. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 1999;399:806-809.
14. Yuan ZM, Shioya H, Ishiko T, Sun X, Gu J, Huang YY, et al. p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage. Nature 1999;399:814-817.
15. Irwin M, Marin MC, Phillips AC, Seelan RS, Smith DJ, Liu W, et al. Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature 2000;407:645-648.
16. Stiewe T, Putzer BM. Role of the p53-homologue p73 in E2F-1-induced apoptosis. Nature Genet 2000;26:464-469.
17. Fontemaggi G, Gurtner A, Strano S, Higashi Y, Sacchi A, Piaggio G, et al. The transcriptional repressor ZEB regulates p73 expression at the crossroad between proliferation and differentiation. Mol Cell Biol 2001;21:8461-8470.
18. Funahashi JL, Sekido K, Murai Y, Kamachi Y, Kondoh H. δ1-crystallin enhancer binding protein δEF1 is a zinc-finger homeodomain protein implicated in post-gastrulation embryogenesis. Development 1993;119:433-443.
19. Genetta T, Ruezinsky D, Kadesh T. Displacement of an E-box binding repressor by basic helix-loop-helix proteins: implications for B-cell specificity of the immunoglobulin heavy chain enhancer. Mol Cell Biol 1994;14:6153-6163.
20. Sekido R, Takagi T, Okanami M, Moribe H, Yamamura M, Higashi Y, et al. Organization of the gene encoding transcriptional repressor δEB1 and cross-species conservation of its domains. Gene Cells 1996;2:771-783.
21. Postigo AA, Depp JL, Taylor JJ, Kroll KL. Regulation of Smad signalling through a differential recruitment of coactivators and corepressors by ZEB proteins. EMBO J 2003;22:2453-2462.
22. Postigo AA, Dean DC. ZEB represses transcription through interaction with the corepressor CtBP. Proc Natl Acad Sci U S A 1999;96:6683-6688.
23. Van Grusnsven LA, Michiels C, van de Putte T, Nelles L, Wuytens G, Verschueren K, et al. Interaction between Smad-interacting protein-1 and the corepressor C-terminal binding protein is dispensable for transcriptional repression of E-cadherin. J Biol Chem 2003;278:26135-26145.
24. Peña C, Garcia JM, Domínguez G, Silva J, García V, Carcereny E, et al. Intronic deletion affecting a negative regulatory region of TP73 is related to breast and colorectal carcinomas. Genes Chromosomes Cancer 2004;39:257-262.
25. Domínguez G, Garcia JM, Peña C, Silva J, García V, Martínez L, et al. ΔTAp73 up-regulation correlates with poor prognosis in human tumors: putative in vivo network involving p73 isoforms, p53 and E2F-1. J Clin Oncol 2006;24:805-815.
26. Peña C, García JM, Silva J, García V, Rodríguez R, Alonso I, et al. E-cadherin and vitamin D receptor regulation by SNAIL and ZEB1 in colon cancer. Clinicopathological correlations. Hum Mol Genet 2005;14:3361-3370.
27. Peña C, García JM, García V, Silva J, Domínguez G, Rodriguez R, et al. The expression levels of the transcriptional regulators p300 and CtBP modulate the correlations between SNAIL, ZEB1, E-cadherin and vitamin D receptor in human colon carcinomas. Int J Cancer 2006;119:2098-2104.
28. Palmer HG, Larriba MJ, Garcia JM, Ordoñez-Moran P, Peña C, Peiro S, et al. Snail represses vitamin D receptor expression and responsiveness in human colon cancer. Nature Med 2004;10:917-919.
29. Domínguez G, Silva J, Silva JM, García JM, Larrondo FJ, Vargas J, et al. Different expression of p14APF defines two groups of breast carcinomas in terms of TP73 expression and TP53 mutational status. Genes Chromosomes Cancer 2001;31:99-106.
30. Concin N, Becker K, Slade N, Erster S, Mueller-Holzner E, Ulmer H, et al. Transdominant ΔTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo. Cancer Res 2004;64:2449-2460.
31. Uramoto H, Sugio K, Oyama T, Nakata S, Ono K, Morita M, et al. Expression of ΔNp73 predicts poor prognosis in lung cancer. Clin Cancer Res 2004;10:6905-6911.
32. Casciano I, Mazzocco K, Boni L, Pagnan G, Banelli B, Allemanni G, et al. Expression of ΔNp73 is a molecular marker for adverse outcome in neuroblastoma patients. Cell Death Differ 2002;9:246-251.
33. Stiewe T, Stanelle J, Theseling CC, Pollmeier B, Beitzingers M, Pützer BM. Inactivation of retinoblastoma (RB) tumor suppressor by oncogenic isoforms of the p53 family member p73. J Biol Chem 2003;278:14230-14236.